J. Biau

Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update

J. Biau, M. Lapeyre, I. Troussier et al. · Radiotherapy and Oncology · 2019 · 233 citations · Full text

Adaptive Radiotherapy, Radiation Therapy, Medicine +10

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun et al. · Annals of Oncology · 2022 · 166 citations · Full text

Ii Trial, Radiation Medicine, Radiation Therapy +10

LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial

Jean Bourhis, Clément Sire, Yungan Tao et al. · Annals of Oncology · 2020 · 63 citations

Advanced Head, Radiation Medicine, Radiation Therapy +8

Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy

J. Moreau, Toufic Khalil, G. Dupic et al. · PLoS ONE · 2018 · 54 citations · Full text

A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.

Xu Sun, Christian Sire, Yungan Tao et al. · Journal of Clinical Oncology · 2018 · 53 citations

Squamous Cell Carcinoma, Immunology, Pharmacotherapy +18